Maddalena C. Barba

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications

Corrigendum to "A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma" [Exp Mol Pathol Volume 146, June 2026, 105049].

Corrigendum to "A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma" [Exp Mol Pathol Volume 146, June 2026, 105049].

Journal: Experimental and molecular pathology
Published: May 28, 2026

A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma.

A WNT/β-catenin-associated transcriptional program predicts survival outcomes in patients with hepatocellular carcinoma.

Journal: Experimental and molecular pathology
Published: January 26, 2026

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study.

Journal: NPJ breast cancer
Published: January 23, 2026

Multidisciplinary minimally invasive planning for synchronous breast cancer and thymoma: a scarless single-stage surgical strategy-a case report and literature review.

Multidisciplinary minimally invasive planning for synchronous breast cancer and thymoma: a scarless single-stage surgical strategy-a case report and literature review.

Journal: Gland surgery
Published: January 22, 2026

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Journal: Biology direct
Published: May 02, 2025

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study.

Journal: Cancers
Published: October 22, 2024

DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.

DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study.

Journal: Cancers
Published: June 26, 2024

Breast and cervical cancer in transgender men: literature review and a case report.

Breast and cervical cancer in transgender men: literature review and a case report.

Journal: Therapeutic advances in medical oncology
Published: January 30, 2024

HER2 mutation as an emerging target in advanced breast cancer.

HER2 mutation as an emerging target in advanced breast cancer.

Journal: Cancer science
Published: January 15, 2024

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study.

Journal: Neoplasia (New York, N.Y.)
Published: September 13, 2023

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.

Journal: Frontiers in oncology
Published: January 27, 2023

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.

Journal: International journal of molecular sciences
Published: October 17, 2022
Showing 1-12 of 140

Last Updated: 09/26/2026